Table 1.
Criteria | Septic Shock Case Definitions and Corresponding Variables Reported in Literature
|
Other Description of Criteria Variables | |||
---|---|---|---|---|---|
Consensus Definitions
|
Other Definitions
|
||||
Bone et al1 | Levy et al2 | SSC111 | Trial-based112 | ||
Infection | Suspected or proven | Suspected or proven | Suspected or proven | Suspected or proven | Bacteremia, culture positive; CDC definitions for infection |
| |||||
SIRS criteria, No. | 2 | One or more of 24 variablesb | 2 | 3 | NA |
| |||||
Septic shock description | Sepsis-induced hypotension despite adequate resuscitation OR receiving vasopressors/Inotropes plus presence of perfusion abnormalities | State of acute circulatory failure characterized by persistent arterial hypotension after adequate resuscitation unexplained by other causes | Sepsis-induced hypotension persisting despite adequate fluid resuscitation | Cardiovascular dysfunction defined as hypotension despite adequate resuscitation or need for vasopressors | Precoded data using ICD-9 and ICD-10 codesc |
| |||||
Hypotension, mm Hg | |||||
| |||||
Systolic BP | <90 | <90 | <90 | <90 | <100 |
| |||||
Decrease in systolic BP | Decrease >40 | Decrease >40 | Decrease >40 | NA<70 | >50% decrease in hypertension |
| |||||
MAP | No | <60 | <70 | Hypotension lasting >1 h after resuscitation | <65 |
| |||||
Adequate resuscitation definition | Not defined | Not defined | Goals set as CVP 8–12 mm Hg; urine output ≥0.5 mL/kg/h; ScvO2 >70% | Not defined | After resuscitation fluids (0.5 L; 1 L; 1.5 L; 20 mL/kg ideal body weight |
| |||||
Vasopressor use | Yes (not absolute requirement) | Yes (CVS SOFA score) | Yes (not absolute requirement) | Yes (not absolute requirement) | Vasoactive drugs required for >30 min |
| |||||
Hypoperfusion abnormalities | Hypoperfusion abnormality defined as lactic acidosis; oliguria; low Glasgow Coma Score | Tissue hypoperfusion defined as serum lactate >1 mmol/L or delayed capillary refill | Tissue hypoperfusion defined as infection-induced hypotension, elevated serum lactate (>4 mmol/L), or oliguria | No description | Serum lactate >2.5 mmol/L; base deficit >5 mEq/L, alkaline reserve <18 mEq/L; CVP <8; PCWP <12 |
| |||||
Data points from included studies, No. (%)d | 39 (75) | 13 (25) | |||
| |||||
Sample size, No. | 158 354 | 8125 | |||
| |||||
Mortality by septic shock definition using random-effects meta analysis, % (95% CI) | 47.2 (42.7–51.7) | 44.2 (38.5–49.9) | |||
| |||||
I2, %e | 99.6 | 95.9 | |||
| |||||
τ2 f | 191.21 | 94.9 | |||
| |||||
P value heterogeneity | <.001 | <.001 |
Abbreviations: BP, blood pressure; CDC, Centers for Disease Control and Prevention; CVP, central venous pressure; CVS, cardiovascular system; ICD, International Classification of Diseases; MAP, mean arterial pressure; NA, not applicable; PCWP, pulmonary capillary wedge pressure; SBP, systolic blood pressure; ScvO2, central venous oxygen saturation; SIRS, systemic inflammatory response syndrome; SOFA, Sequential [Sepsis-related] Organ Failure Assessment; SSC, Surviving Sepsis Campaign.
SI conversion factor: To convert serum lactate values to mg/dL, divide by 0.111.
Levy et al highlight an extended variable list as a replacement for SIRS criteria consisting of general (n = 7); inflammatory (n = 5); hemodynamic (n = 3); organ dysfunction (n = 7) and tissue perfusion (n = 2) variables.2
Different ICD-9 codes are reported to identify septic shock in the literature. These include shock without trauma code 785.50 with all subcodes (785.51, 785.52, 785.59), hypotension code 458 with subcodes (458.0, 458.8 458.9), cardiovascular failure code 427.5 and the nonspecific low blood pressure code 796.3.
Studies reporting 2 or more subsets,6,7,30,32 current study (whole population and Group 1), and GiViTI database account for 52 data points from 44 studies. See Figure 2 notes for further details.
I2 is the percentage of between-study heterogeneity that is attributable to a true variability in septic shock mortality, rather than sampling variation, implying heterogeneity.
τ2 refers to the between-study variance within groups in random-effects meta-analysis.